Patient, tumor and treatment characteristics according to PIK3CA status and the type of PIK3CA mutations, as determined by Sanger/qPCR.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
BCS, breast conserving surgery; CMF, cyclophosphamide-methotrexate-5-fluorouracil; E, epirubicin; HR, hormone receptor; MAC, molecular apocrine; MRM, modified radical mastectomy; NR, not reported; PIK3CAhel, mutations present in the helical (and kinase) domain; PIK3CAkin, mutations present only in the kinase domain; PIK3CAwt, PIK3CA wild-type; T, paclitaxel. Patient, tumor and treatment characteristics according to PIK3CA status and the type of PIK3CA mutations, as determined by Sanger/qPCR.
创建时间：
2015-10-09
